Raymond James Financial
ANIP icon

Raymond James Financial’s ANI Pharmaceuticals ANIP Stock Holding History

Raymond James Financial’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
131,270
+50,650
+63% +$4.06M ﹤0.01% 2080
2026
Q1 		$6.17M Sell
80,620
-236
-0.3% -$18.4K ﹤0.01% 2429
2025
Q4 		$6.39M Sell
80,856
-6,235
-7% -$540K ﹤0.01% 2313
2025
Q3 		$7.98M Sell
87,091
-10,608
-11% -$865K ﹤0.01% 2102
2025
Q2 		$6.37M Sell
97,699
-2,465
-2% -$160K ﹤0.01% 2205
2025
Q1 		$6.71M Buy
100,164
+29,338
+41% +$1.75M ﹤0.01% 2124
2024
Q4 		$3.92M Buy
+70,826
New +$4.07M ﹤0.01% 2473

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's ANIP Position: Q2 2026 in Review

Raymond James Financial increased its ANI Pharmaceuticals (ANIP) stake by 63% in Q2 2026, buying an estimated $4.06M and bringing the position to 131,270 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

Raymond James Financial first reported a position in ANIP in Q4 2024 and has held it in 7 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Raymond James Financial held 131,270 shares of ANI Pharmaceuticals worth $10.9M as of Q2 2026.
  • Raymond James Financial bought 50,650 ANI Pharmaceuticals shares in Q2 2026, an estimated $4.06M.
  • ANI Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2080 holding.
  • Raymond James Financial first reported a position in ANI Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.